Digital repository of Slovenian research organisations

Show document
A+ | A- | Help | SLO | ENG

Title:Preconception use of GLP-1 and GLP-1/GIP receptor agonists for obesity treatment
Authors:ID Koceva, Andrijana (Author)
ID Janež, Andrej (Author)
ID Jensterle Sever, Mojca (Author)
Files:.pdf PDF - Presentation file, download (1,41 MB)
MD5: FDF25620A7D2AF377C9377FF4F6F0E9C
 
URL URL - Source URL, visit https://www.sciencedirect.com/science/article/abs/pii/S1521690X25000715
 
Language:English
Typology:1.02 - Review Article
Organization:Logo UKC LJ - Ljubljana University Medical Centre
Abstract:Obesity is rising among women of reproductive age and significantly contributes to subfertility. If conception occurs, maternal obesity is associated with increased risks for both maternal and neonatal complications, with potential long-term effects on the offspring's health. Current clinical guidelines emphasize the importance of preconception weight optimization in women with obesity to reduce maternal and fetal risks. Amid the rising use of incretin-based anti-obesity medications, particularly among young women, their potential role in preconception care is receiving growing clinical and research interest. With unplanned pregnancies remaining common, incidental exposure during early pregnancy is becoming more likely. In parallel, there is increasing interest in the potential of these agents to support preconception weight loss and enhance fertility outcomes in women with obesity. This narrative review examines the current human evidence on GLP-1 and dual GLP-1/GIP receptor agonists approved for obesity treatment, focusing on their potential role in preconception care and addressing key safety considerations and challenges related to their use during the preconception period, as well as inadvertent exposure in early pregnancy.
Keywords:GLP-1 receptor agonist, GLP-1/GIP receptor agonist, preconception care
Publication status:Published
Publication version:Version of Record
Year of publishing:2025
Number of pages:str. 1-10
Numbering:Vol. 39, iss. 6
PID:20.500.12556/DiRROS-24894 New window
UDC:616.4
ISSN on article:1521-690X
DOI:10.1016/j.beem.2025.102038 New window
COBISS.SI-ID:250744067 New window
Publication date in DiRROS:23.12.2025
Views:7
Downloads:5
Metadata:XML DC-XML DC-RDF
:
Copy citation
  
Share:Bookmark and Share


Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Record is a part of a journal

Title:Baillière's best practice & research. Clinical Endocrinology and metabolism
Shortened title:Baillière's Best Pract Res Clin Endocrinol Metab
Publisher:Baillière Tindall
ISSN:1521-690X
COBISS.SI-ID:2071060 New window

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.

Secondary language

Language:Slovenian
Keywords:agonist receptorja GLP-1, agonist receptorja GLP-1/GIP, predzanositvena oskrba


Back